Home
>
National Drug Code (NDC)
>
hybrid CF
hybrid CF - 49804-101-24 - (APAP 500 mg Phenylephrine HCL 5 mg Chlorpheniramine maleate 2 mg)
Drug Information of hybrid CF
| Product NDC: | 49804-101 |
| Proprietary Name: | hybrid CF |
| Non Proprietary Name: | APAP 500 mg Phenylephrine HCL 5 mg Chlorpheniramine maleate 2 mg |
| Active Ingredient(s): | 500; 2; 5 mg/1; mg/1; mg/1 & nbsp; APAP 500 mg Phenylephrine HCL 5 mg Chlorpheniramine maleate 2 mg |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of hybrid CF
| Product NDC: | 49804-101 |
| Labeler Name: | Hybrid-Rx LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100203 |
Package Information of hybrid CF
| Package NDC: | 49804-101-24 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (49804-101-24) > 12 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Information of hybrid CF
| NDC Code | 49804-101-24 |
| Proprietary Name | hybrid CF |
| Package Description | 1 BLISTER PACK in 1 CARTON (49804-101-24) > 12 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 49804-101 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | APAP 500 mg Phenylephrine HCL 5 mg Chlorpheniramine maleate 2 mg |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100203 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Hybrid-Rx LLC |
| Substance Name | ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 500; 2; 5 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |
